MedTrace Logo

BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal

NCT03367247 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 121

Last updated 2026-03-10

Study results available
· View outcomes & findings →

Summary

This research study is evaluating a new intervention, BOLSTER, which was designed to provide more support for patients with gynecologic and gastrointestinal cancers and their caregivers after a hospitalization.

Conditions

Interventions

BEHAVIORAL

BOLSTER

BOLSTER provides patients and caregivers with education and skills training, symptom management, and support across care settings over a four-week period.

OTHER

Enhanced Discharge Planning (EDP)

EDP provides patients and caregivers a single session of education and skills training, symptom management, and support.

Sponsors & Collaborators

Principal Investigators

  • Alexi A Wright, MD, MPH · Dana-Farber Cancer Institute

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-24
Primary Completion
2022-06-30
Completion
2023-07-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03367247 on ClinicalTrials.gov